■論説
臨床現場における薬剤師の役割（11）―外来がん薬物治療患者に対する連携充実加算への取り組み
田中 弘人, 輪湖 哲也, 伊勢 雄也
日本医科大学付属病院薬剤部
The Role of the Pharmacist in Clinical Settings (11): The Additional Fee for Collaboration Enhancement for Outpatient Chemotherapy
Hiroto Tanaka, Tetsuya Wako and Yuya Ise
Department of Pharmaceutical Service, Nippon Medical School Hospital
At present, chemotherapy for cancer is mainly administered on an outpatient basis, and prescriptions for some oral anticancer drugs and drugs to manage side effects are regularly filled at dispensing pharmacies. Therefore, collaboration between medical institutions and dispensing pharmacies is becoming ever more important. We have now started calculating the costs of the additional fee for collaboration enhancement that was newly established in the April 2020 revision of medical fees. As a tool for sharing information with dispensing pharmacies, we use regimen collaboration sheets and tracing reports. In the year since medical fees were revised, we have calculated a total of 666 additional fees for collaboration enhancement, and we have received 225 tracing reports from dispensing pharmacies. The challenge for the future will be to further increase the number of calculations and strengthen collaboration by improving information sharing tools.
日医大医会誌 2022; 18(3), 282-288
Key words
cancer treatment, cancer pharmacotherapy, outpatient chemotherapy, team approach, oncology pharmacist
Correspondence to
Hiroto Tanaka, Department of Pharmaceutical Service, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
E-mail：tanaka-hrt@nms.ac.jp
受付：2022年2月14日 受理：2022年3月23日 |
全文PDF